Healthcare Professionals

Here you will find a collection of scientific journal articles related to the research of medical marijuana and the registration link to the Virtual Cannabis CE Event.


This cannabis education lecture series is intended for physicians, physician assistants, pharmacists, nurses/nurse practitioners, first responders, and other health care professionals involved or interested in toxicology and emergency care. 

Registration is FREE for all attendees. Click the link below to register.

Cannabis Education for Healthcare Professionals Tickets, Mon, Dec 4, 2023 at 12:00 AM | Eventbrite

Adverse Effects


Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spasticity using tetrahydrocannabinol:cannabidiol (THC:CBD) 
Cannabinoid Hyperemesis Syndrome  
Cannabis and Reversible Cerebral Vasoconstriction Syndrome  
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review  
Potential Pharmacokinetic Drug-Drug Interactions Between Cannabinoids and Drugs Used For Chronic Pain  
Adverse Effects of Cannabis Scientifically Verified, a World First  











Drug-Drug Interaction

Migraine and Headaches

Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review The Use of Cannabis for Headache Disorders
Potential Pharmacokinetic Drug-Drug Interactions Between Cannabinoids and Drugs Used For Chronic Pain Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population
Effects of Cannabis Use on Sedation Requirements for Endoscopic Procedures Short- and Long-Term Effects of Cannabis on Headache and Migraine


Multiple Sclerosis 


Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial Persistent cannabis users show neuropsychological decline from childhood to midlife
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis Association between Lifetime Marijuana Use and Cognitive Function in Middle Age The Coronary Artery Risk Development in Young Adults (CARDIA) Study
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis  
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial  
Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study  





Cannabinoids for adult cancer-related pain: systematic review and meta-analysis Cannabis and Pain: A Clinical Review
An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics Cannabis and Cannabinoids for Chronic Pain
Prospects for the Use of Cannabinoids in Oncology and Palliative Care Practice: A Review of the Evidence Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials
Opportunities for cannabis in supportive care in cancer Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data
Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy Cannabis-based medicines for chronic neuropathic pain in adults
Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study Smoked cannabis for chronic neuropathic pain: a randomized controlled trial
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial



The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial  
Cancer Patients' Experiences With Medical Cannabis-Related Care  



Pregnancy and Breastfeeding


Impact of Medical Marijuana on Pregnant and Lactating Women Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
Marijuana Use by Breastfeeding Mothers and Cannabinoid Concentrations in Breast Milk A systematic review of the antipsychotic properties of cannabidiol in humans
Transfer of Inhaled Cannabis Into Human Breast Milk Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders
  The use of medicinal marijuana for posttraumatic stress disorder: a review of the current literature.





Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010 Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
Association between medical cannabis laws and opioid overdose mortality has reversed over time Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome: A Randomized Clinical Trial
  Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome
  Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
  Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome




Acute effect of vaporized Cannabis on sleep and electrocortical activity  
No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study  
Cannabis, Cannabinoids, and Sleep: a Review of the Literature  
Cannabidiol in Anxiety and Sleep: A Large Case Series  
Differential Effects of Addictive Drugs on Sleep and Sleep Stages  
Cannabis for restless legs syndrome: a report of six patients  
More evidence of cannabis efficacy in restless legs syndrome